[topsearch__bar__shortcode]

October 2020

HOOK Stock

Top 15 Information Technology Stocks You Should Be Holding

Leave a Comment / Featured, Market News /

The demand for IT services is continuously increasing and is driven by rapid technological changes. Companies that are operating in the Information Technology Services industry, offer services such as software support, data processing facilities management, and computer systems design. The demand for IT technologies is also increasing with the passage of time. Various technologies such […]

Top 15 Information Technology Stocks You Should Be Holding Read More »

Gridsum Holding (NASDAQ: GSUM) Inks Merger Agreement With Gridsum Corporation

Leave a Comment / Featured /

Gridsum Holding Inc. (NASDAQ: GSUM) has announced today that it has signed a merger agreement with Gridusm Corporation (Parent) and Gridsum Growth Inc., which is a wholly-owned subsidiary of the parent. As per the agreement, the company will be bought by an investor consortium led by Mr. Guosheng Qi who is the Chairman,  in an

Gridsum Holding (NASDAQ: GSUM) Inks Merger Agreement With Gridsum Corporation Read More »

Enlivex (NASDAQ: ENLV) Announces Positive Result Of Allocetra In COVID-19 Patients

Leave a Comment / Featured /

Enlivex Therapeutics Ltd. (NASDAQ: ENLV) has revealed today that the clinical trial of AllocetraTM has shown positive results in COVID-19 patients who were in critical condition. The company has conducted a clinical trial that included five patients, two patients were in critical condition and three patients were in severe condition. But following the treatment of

Enlivex (NASDAQ: ENLV) Announces Positive Result Of Allocetra In COVID-19 Patients Read More »

IGC Stock

I-Mab (NASDAQ: IMAB) Gets China CDE Approval To Start Phase 3 Clinical Trial Of Eftansomatropin

Leave a Comment / Featured, Mid Day Movers /

I-Mab (NASDAQ: IMAB), a biotechnology company announced Wednesday that it has got the green signal from China Center for Drug Evaluation (CDE) to commence the Phase 3 clinical trial Eftansomatropin. Eftansomatropin is a  long-acting recombinant human growth hormone (rhGH) used to treat the deficiency of growth hormone in pediatric patients. In Phase 1 and 2

I-Mab (NASDAQ: IMAB) Gets China CDE Approval To Start Phase 3 Clinical Trial Of Eftansomatropin Read More »

SMAR Stock

Houston Energy Corporation [HUSA] Still In a Buy Zone after Bullish Breakout

Leave a Comment / Featured, Market News /

Houston Energy Corporation [NYSE: HUSA] is in an interesting zone right now. It was in a breakout two days ago, and while short sellers have tried to drive the price down, overall momentum remains bullish. At the moment, downside pressure is driven by a decline in demand for oil due to the COVID-19 pandemic. However,

Houston Energy Corporation [HUSA] Still In a Buy Zone after Bullish Breakout Read More »

Stocks
Telegraph

At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.

About

Categories

Social Links

Facebook Twitter Youtube Instagram Linkedin